Posts Tagged ‘ Ocella ’

The Mass Tort Muser Ponders Yaz Lawsuits

October 26th, 2010. By Mass Tort Muser

Yaz (and its sib, Yasmin) has been under fire over the past couple of years. Hell hath no fury, right? And there are definitely some women out there feeling a bit scorned by big pharma on this one…

But talk about the pendulum swinging back in the opposite direction. It wasn’t all that long ago that we (women, that is) were ecstatic that finally, yes finally, there was a mere pill—such a teeny tiny helper!—that could save us from unwanted pregnancy and that God-forsaken monthly interruption—cramps and all. (Insert a “Right-on!” shout-out to Ms. Steinem, women’s lib and a few burnt bras…).

Fast-forward almost forty years…and the pill delivers zit relief, too—our cup runneth over! Breakout banisher is basically how Yaz positioned itself on center stage of the contraception market—and how it netted not only a whole new generation of pretty young things as groupies but also a wrist-slap from the FDA. Seems telling women about how clear their skin would be without telling them about potential little side effects like deep vein thrombosis or perhaps the need for gallbladder surgery wasn’t such a slick marketing move. At least they didn’t try to get shelf space next to Clearasil.

But you know all that. And here’s where the musing and pondering kick in…

Given what’s been going on with Yaz, you may be wondering why on earth there isn’t some big brouhaha going on—you know, one of those class actions. It seems whenever there’s a product—be it a lawnmower, Expedia.com’s hotel reservations, or Similac baby formula—that doesn’t do what it says it will do or causes undo harm, there’s a class action. So, what’s up with Yaz? Where the heck is my “opt in” claim form? Was I not invited?!?

Let’s look at how some of the details rack up: indeed, lots of women allege to have been harmed by Yaz—enough perhaps to even be considered a “class” or at least a sizeable cocktail party. And possible Yaz side effects are numerous—and not just your run of the mill “honey I’ve got a headache gonna lie down” type. No, these are biggies: gallbladder problems, deep vein thrombosis, pulmonary embolism, heart attack, stroke… Keep in mind, too, the women getting Yaz prescriptions filled are, obviously, within child-bearing age, so they’re younger—not the typical age-range for heart attack or stroke, for example.

So why not a Yaz class action? Why not a little “you may be part of a Yaz lawsuit” postcard in the mailbox or a full-page ad of legalese in People magazine? The answer is because Read the rest of this entry »

Tags: Mass Tort, Ocella, Yasmin, Yaz, Yaz lawsuit
Posted in Defective Products, Drugs/Medical, Emerging Issues, Personal Injury | No Comments »

Yaz by the Numbers: the Warning, the Recall, the Profit, the Lawsuits

May 12th, 2010. By Kristine B

As Bayer adds new warnings to its birth control pills in the wake of lawsuits regarding Yaz and Yasmin, we thought it would be a good idea to break Yasmin and Yaz down by the numbers. 

2001: The year Yasmin came on the market

2006: The year Yaz came on the market

2008: The year Bayer (maker of Yasmin and Yaz) received a warning from the FDA about overstating the pills’ effectiveness while minimizing their risks

2008: The year Ocella receives FDA approval; Ocella is the generic version of Yaz that is manufactured by Barr, which is owned by Teva

2009: The year Bayer launches new $20 million ad campaign to address the FDA’s warning

2009: The year the FDA issued a recall on certain lots of Yaz and Ocella for “Out of Specification analytical value for chemical assays of drospirenone and ethinyl estradiol was averaged with another analytical value to provide a reported result that was within specification.”

2010: The year Bayer added new warnings about the risks of blood clots linked to Yasmin and Yaz

1,100: Approximate number of lawsuits filed against Bayer regarding Yasmin and Yaz

$1.64 billion: Approximate profit Bayer reportedly made from Yasmin and Yaz during 2009

993: Number of reports the FDA received by November, 2009, of cases of pulmonary embolism linked to Yaz or Yasmin

487: Number of reports the FDA received of deep vein thrombosis

229: Number of reports the FDA received of other blood clots

800: Number of Canadians who have joined class-action lawsuits against Bayer

50: Number of women who reportedly died after taking Yaz, as of July, 2009

6.3: The number of times the risk of developing a blood clot is increased in women who take Yasmin or Yaz, according to a study in the British Medical Journal.

Note: Bayer has defended the birth control pills, saying they are safe and effective.

All stats taken from the FDA.gov, The New York Times, Los Angeles Times, Calgary Herald, BusinessWeek, The Bulletin (Philadelphia) and WISH tv, in addition to the British Medical Journal.

Tags: Birth Control, Contraceptive, Ocella, Yasmin, Yaz
Posted in Drugs/Medical | No Comments »